Sujal Patel's guest appearances

Sujal Patel

DealMakers: Entrepreneur | Startups | Venture Capital

Innovating with Scott Amyx

Tough Tech Today with Meyen and Miller

Peter Bailis

Vijay Balasubramaniyan

Joshua Motta

Cyriac Roeding

Will Herman

Amir Elichai

Michael Litt

Sean Harper

Kara Goldin

David Klein

Guy Kawasaki

Andrew Smith

John Kim

Joseph Cohen

Jason Gardner

OwlTail

In one sentence...Human health upgrades may be unlocked by a data storage expert focused on probing the proteome. Overview:It’s not everyday that one hears about the crucial relationship between digital data storage and biology, yet this is core to Sujal Patel’s work leading Nautilus Biotechnology. By any measure already an accomplished tech entrepreneur, Sujal’s experience building Isilon Systems (acquired by EMC for $2.5 billion) became a perfect, if non-obvious, ingredient for disentangling the complexities of proteins.If successful in analyzing the proteins within thousands of cells, Patel, his co-founder Parag Mallick, and their team may discover new drugs for present and emerging diseases. Pioneering the birth of this new proteome sequencer instrument involves deep and broad interdisciplinary collaboration. Patel says, “On our staff are mechanical engineers, software engineers, electrical engineers, and biophysicists working side-by-side with biochemists, organic chemists, bioengineering majors – all these disciplines come together to build a complete solution.” Topic Timecodes:[00:00] Episode preview[00:59] Nautilus Biotechnology and why the need to understand what’s going on at the protein level[05:03] Isilon to Nautilus[11:23] Early stages of Nautilus[14:13] Tough stuff at Nautilus[19:13] Goal of Nautilus[21:14] How Sujal went about learning a completely new field [24:17] What exactly is Nautilus building[26:54] Broader landscape of proteomic analysis companies[32:17] What is unique about Nautilus Bio[35:53] Nautilus Bio’s relationship with customers[38:22] Nautilus and COVID-19 / other pandemics[41:37] Going faster at Nautilus due to high demand[43:51] Adjusting to life with COVID-19 at Nautilus[48:02] Priorities for Nautilus in the near-term[50:58] What’s been the most fun for Sujal in building Nautilus?[53:36] Shameless plugs

<h1>In one sentence...</h1>Human health upgrades may be unlocked by a data storage expert focused on probing the proteome. <h1>Overview:</h1>It’s not everyday that one hears about the crucial relationship between digital data storage and biology, yet this is core to Sujal Patel’s work leading Nautilus Biotechnology. By any measure already an accomplished tech entrepreneur, Sujal’s experience building Isilon Systems (acquired by EMC for $2.5 billion) became a perfect, if non-obvious, ingredient for disentangling the complexities of proteins.If successful in analyzing the proteins within thousands of cells, Patel, his co-founder Parag Mallick, and their team may discover new drugs for present and emerging diseases. Pioneering the birth of this new proteome sequencer instrument involves deep and broad interdisciplinary collaboration. Patel says, “On our staff are mechanical engineers, software engineers, electrical engineers, and biophysicists working side-by-side with biochemists, organic chemists, bioengineering majors – all these disciplines come together to build a complete solution.”  <h1>Topic Timecodes:</h1>[00:00] Episode preview [00:59] Nautilus Biotechnology and why the need to understand what’s going on at the protein level [05:03] Isilon to Nautilus [11:23] Early stages of Nautilus [14:13] Tough stuff at Nautilus [19:13] Goal of Nautilus [21:14] How Sujal went about learning a completely new field  [24:17] What exactly is Nautilus building [26:54] Broader landscape of proteomic analysis companies [32:17] What is unique about Nautilus Bio [35:53] Nautilus Bio’s relationship with customers [38:22] Nautilus and COVID-19 / other pandemics [41:37] Going faster at Nautilus due to high demand [43:51] Adjusting to life with COVID-19 at Nautilus [48:02] Priorities for Nautilus in the near-term [50:58] What’s been the most fun for Sujal in building Nautilus? [53:36] Shameless plugs

$2.5B Exit Entrepreneur, Sujal Patel, is Creating a Proteomics Startup to Upgrade Human Health

Nautilus Biotechnology offers a high-throughput, low-cost platform for analyzing and quantifying the human proteome.

Nautilus Biotechnology offers a high-throughput, low-cost platform for analyzing and quantifying the human proteome.

Interview with Sujal Patel CEO of Nautilus Biotechnology

Jeff Bezos

Sujal Patel is the cofounder and CEO of Nautilus Biotechnology which offers a high-throughput, low-cost platform for analyzing and quantifying the human proteome. The company has raised over $100 million from top tier investors such as Andreessen Horowitz, Madrona Venture Group, AME Cloud Ventures, Vulcan Capital, Perceptive Advisors, Bezos Expeditions, Bolt Ventures, and Defy Ventures to name a few.  Prior to this, he cofounded Isilon which he sold to EMC for $2.6 billion.

Sujal Patel On Selling His First Business For $2.6 Billion And Now Raising $108 Million From Jeff Bezos And Others To Improve Medical Diagnostics